Modern Myoma Treatment in the Last 20 Years: A Review of the Literature

Abstract EN

Myomas, also known as fibroids, are a specific characteristic of the human species.

No other primates develop fibroids.

At a cellular level, myomas are benign hyperplastic lesions of uterine smooth muscle cells.

There are interesting theoretical concepts that link the development of myomas in humans with the highly specific process of childbirth from an upright position and the resulting need for greatly increased “expulsive” forces during labor.

Myomas might be the price our species pays for our bipedal and highly intelligent existence.

Myomas affect, with some variability, all ethnic groups and approximately 50% of all women during their lifetime.

While some remain asymptomatic, myomas can cause significant and sometimes life-threatening uterine bleeding, pain, infertility, and, in extreme cases, ureteral obstruction and death.

Traditionally, over 50% of all hysterectomies were performed for fibroids, leading to a significant healthcare burden.

In this article, we review the developments of the past 20 years with regard to multiple new treatment strategies that have evolved during this time.